Literature DB >> 19797180

Platelet dysfunction in intraparenchymal hemorrhage.

Claire J Creutzfeldt, Kyra J Becker, W T Longstreth, David L Tirschwell, Jonathan R Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19797180      PMCID： PMC8930190          DOI： 10.1161/STROKEAHA.109.561191

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  11 in total

1.  Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage.

Authors:  Joseph P Broderick
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

2.  Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.

Authors:  Christian Foerch; Matthias Sitzer; Helmuth Steinmetz; Tobias Neumann-Haefelin
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

3.  Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.

Authors:  K Toyoda; Y Okada; K Minematsu; M Kamouchi; S Fujimoto; S Ibayashi; T Inoue
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

4.  Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.

Authors:  Andrew M Naidech; Borko Jovanovic; Storm Liebling; Rajeev K Garg; Sarice L Bassin; Bernard R Bendok; Richard A Bernstein; Mark J Alberts; H Hunt Batjer
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

5.  Effect of aspirin and warfarin on early survival after intracerebral haemorrhage.

Authors:  H Carl Hanger; Valerie J Fletcher; Tim J Wilkinson; Allan J Brown; Chris M Frampton; Richard Sainsbury
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

6.  Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage.

Authors:  Claire J Creutzfeldt; Jonathan R Weinstein; W T Longstreth; Kyra J Becker; Thomas O McPharlin; David L Tirschwell
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 May-Jun       Impact factor: 2.136

7.  A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.

Authors:  Marie Lordkipanidzé; Chantal Pharand; Erick Schampaert; Jacques Turgeon; Donald A Palisaitis; Jean G Diodati
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

8.  Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.

Authors:  L H Sansing; S R Messe; B L Cucchiara; S N Cohen; P D Lyden; S E Kasner
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

9.  Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.

Authors:  Karine Lacut; Gregoire Le Gal; Romuald Seizeur; Gwenael Prat; Dominique Mottier; Emmanuel Oger
Journal:  Fundam Clin Pharmacol       Date:  2007-06       Impact factor: 2.748

10.  Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.

Authors:  Valeria Caso; Maurizio Paciaroni; Michele Venti; Andrea Alberti; Francesco Palmerini; Paolo Milia; Antonia M R Billeci; Giorgio Silvestrelli; Sergio Biagini; Giancarlo Agnelli
Journal:  Cerebrovasc Dis       Date:  2007-06-28       Impact factor: 2.762
View more
  1 in total

1.  Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy.

Authors:  Patrick K Davis; Harsha Musunuru; Mark Walsh; Robert Cassady; Robert Yount; Andrew Losiniecki; Ernest E Moore; Max V Wohlauer; Janet Howard; Victoria A Ploplis; Francis J Castellino; Scott G Thomas
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.